MPWT
IMNM icon

MassMutual Private Wealth & Trust’s Immunome IMNM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$107 – 2442
2025
Q4 		$107 Buy
+5
New +$88 ﹤0.01% 2336
2022
Q2 		– Sell
-514
Closed -$3K – 1610
2022
Q1 		$3K Hold
514
– – ﹤0.01% 1050
2021
Q4 		$7K Buy
+514
New +$9.17K ﹤0.01% 816

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

MassMutual Private Wealth & Trust's IMNM Position: Q1 2026 in Review

MassMutual Private Wealth & Trust sold out of Immunome (IMNM) in Q1 2026, closing a stake of 5 shares — an estimated $107 sold.

MassMutual Private Wealth & Trust first reported a position in IMNM in Q4 2021 and held it in 3 quarters. The position peaked at $7K in Q4 2021. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • MassMutual Private Wealth & Trust reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 5 Immunome shares in Q1 2026, an estimated $107.
  • MassMutual Private Wealth & Trust first reported a position in Immunome in Q4 2021 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's Immunome position peaked at $7K in Q4 2021.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2026, filed 13 Apr 2026.